Abstract

Background: In recent years more attention is paid to the methods of interventional treatment of coronary artery disease. However, despite the numerous clinical studies the problem of stent restenosis after interventional procedures remains an important one. The studies of the molecular mechanisms of restenosis of coronary arteries and findings for new genetically determined predictors of restenosis after stenting become vital and essential. The NO-synthase influence on the development of endothelial dysfunction is practically assured, but the studies on the NOS genes' polymorphism effect on the incidence rate of in-stent restenosis are isolated and based on a limited number of clinical observations. The determined facts demonstrate the relevance of the conducted study, the results of which formed a new understanding of the role of NO-synthase genes in the predisposition to hyper-proliferative stents in patients with coronary artery disease. Aims: Set association between the eNOS gene polymorphisms and the risk of restenosis in patients with coronary artery disease hospitalized for coronary restenosis.Materials and methods: We examined 484 patients with the verified diagnosis of the ischemic heart disease who underwent treatment at the unit of atherosclerosis and chronic coronary heart disease of «Cardiology Research Institute». Stenting of coronary arteries was performed in 210 people. The group of a restenosis enrolled 60 patients and the group without restenosis — 150. Genotyping was performed by non-enzymatic technique for isolation of genomic DNA from the venous blood of the surveyed, NOS genes' polymorphisms were detected by polymerase chain reaction (PCR). Results: The established development of in-stent restenosis was associated with the following eNOS gene polymorphisms: VNTR ― in homozygotes for the minor allele (genotype aa) and heterozygotes (genotype ab); 894G/T ― in heterozygotes (the GT genotype) and homozygotes (TT genotype).Conclusions: VNTR and 894G/T polymorphisms of eNOS gene are associated with risk for restenosis and can serve as additional markers for risk of restenosis after coronary stenting.

Highlights

  • In recent years more attention is paid to the methods of interventional treatment of coronary artery disease

  • Set association between the eNOS gene polymorphisms and the risk of restenosis in patients with coronary artery disease hospitalized for coronary restenosis

  • Materials and methods: We examined 484 patients with the verified diagnosis of the ischemic heart disease who underwent treatment at the unit of atherosclerosis and chronic coronary heart disease of «Cardiology Research Institute»

Read more

Summary

Полиморфизм гена еNOS как фактор риска рестенозирования в стенте

На сегодняшний день становятся актуальными изучение молекулярных механизмов рестенозирования коронарных артерий, а также поиск новых генетически обусловленных предикторов развития рестеноза после стентирования. Вышесказанное свидетельствует об актуальности данного исследования, результаты которого сформировали новые представления о роли генов NO-синтаз в формировании предрасположенности к гиперпролиферации стентов у больных ИБС. Цель исследования: установить ассоциацию полиморфизмов гена eNOS с риском рестенозирования у пациентов с ИБС, госпитализированных по поводу рестеноза коронарных артерий. В основу данной работы положены результаты целенаправленного обследования 484 пациентов с верифицированным диагнозом ИБС, находившихся на лечении в отделении атеросклероза и хронической ишемической болезни сердца ФГБНУ «Научно-исследовательский институт кариологии» СО РАМН. Полиморфизмы VNTR и 894G/T гена eNOS ассоциированы с риском развития рестеноза и могут применяться как дополнительные маркеры риска развития рестеноза после стентирования коронарных артерий. Association of eNOS Gene Polymorphisms as a Risk Factor of Coronary In-stent Restenosis

Background
VNTR bb
СI р bb
Дополнительные результаты исследования В сибирской популяции сочетание генотипов
Findings
Конфликт интересов
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call